Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.22.2.2
Cover - shares
 9 Months Ended
Sep. 30, 2022
Nov. 13, 2022
Document Type 10-Q  
Entity Registrant Name NRX Pharmaceuticals, Inc.  
Entity Central Index Key 0001719406  
Entity Filer Category Non-accelerated Filer  
Amendment Flag false  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity File Number 001-38302  
Entity Tax Identification Number 82-2844431  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Entity Current Reporting Status Yes  
Entity Incorporation, State or Country Code DE  
Entity Address, State or Province DE  
Entity Address, Address Line One 1201 Orange Street  
Entity Address, Address Line Two Suite 600  
Entity Address, City or Town Wilmington  
Entity Address, Postal Zip Code 19801  
City Area Code 484  
Local Phone Number 254-6134  
Entity Common Stock, Shares Outstanding   67,641,314
Common Stock    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NRXP  
Security Exchange Name NASDAQ  
Common stock warrant [Member]    
Title of 12(b) Security Warrants to purchase one share of Common Stock  
Trading Symbol NRXPW  
Security Exchange Name NASDAQ